Australia's Therapeutic Goods Administration has approved a new COVID booster by Pfizer targeting the JN.1 sub-variant of Omicron. Despite evolving variants, boosters remain crucial, especially for ...
So an annual COVID booster is not considered enough for some more vulnerable people. For adults aged 65 to 74, a booster is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback